Post-earnings recap
Reported
Thu, Mar 18, 2021
EPS actual
$-0.22
EPS est.
$-0.28
EPS surprise
+22.26%
1-day move
-7.21%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report indicates that Legend Biotech faced challenges, resulting in a loss per share that exceeded expectations. However, the lack of revenue data and guidance contributed to a negative stock reaction, with shares falling by over 7%. Investors may be concerned about the company's future prospects without clear direction from management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | -$0.22 | N/A | +22.26% |
| Revenue | N/A | N/A | N/A |
Management expressed caution regarding future performance. They highlighted ongoing challenges but did not offer specific insights into revenue expectations.
Management did not provide specific revenue figures or future guidance.
The company acknowledged challenges in the current market environment.